Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya Cao

Showing results (451-460 of 492) with videos related to

Pageof 50
Sort By:
Signal Transduction and Targeted Therapy|September 30, 2020
The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like propertiesNa Liu, Rui Yang, Ying Shi, et al.
BMC Cancer|August 3, 2019
Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic targetXiao-Lu Ma, Yun-Fan Sun, Bei-Li Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2013
Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomasYa Cao, Lifang Yang, Wuzhong Jiang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 12, 2019
TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resectionJin-Wu Hu, Zhang-Fu Yang, Jia Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular CarcinomaMeng Duan, Shyamal Goswami, Jie-Yi Shi, et al.
Nature Communications|November 9, 2019
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variantQipan Deng, Hui Hu, Xinfang Yu, et al.
Cancer Letters|June 4, 2016
EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinomaJingchen Lu, Min Tang, Hongde Li, et al.
Cancer Research|March 29, 2018
A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53Chao Mao, Xiang Wang, Yating Liu, et al.
Molecular Metabolism|April 1, 2020
Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesisFeng Shi, Ya He, Jiangjiang Li, et al.
Journal of Cancer|August 17, 2019
KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal TransitionBo Hu, Jian-Wen Cheng, Jin-Wu Hu, et al.
Pageof 50

Showing results (451-460 of 492) with videos related to

Sort By:
Pageof 50
Signal Transduction and Targeted Therapy|September 30, 2020
The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like propertiesNa Liu, Rui Yang, Ying Shi, et al.
BMC Cancer|August 3, 2019
Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic targetXiao-Lu Ma, Yun-Fan Sun, Bei-Li Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2013
Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomasYa Cao, Lifang Yang, Wuzhong Jiang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 12, 2019
TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resectionJin-Wu Hu, Zhang-Fu Yang, Jia Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular CarcinomaMeng Duan, Shyamal Goswami, Jie-Yi Shi, et al.
Nature Communications|November 9, 2019
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variantQipan Deng, Hui Hu, Xinfang Yu, et al.
Cancer Letters|June 4, 2016
EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinomaJingchen Lu, Min Tang, Hongde Li, et al.
Cancer Research|March 29, 2018
A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53Chao Mao, Xiang Wang, Yating Liu, et al.
Molecular Metabolism|April 1, 2020
Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesisFeng Shi, Ya He, Jiangjiang Li, et al.
Journal of Cancer|August 17, 2019
KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal TransitionBo Hu, Jian-Wen Cheng, Jin-Wu Hu, et al.
Pageof 50